348 related articles for article (PubMed ID: 28213517)
1. The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.
Zhang A; Peng B; Huang P; Chen J; Gong Z
J Biol Chem; 2017 Apr; 292(16):6461-6467. PubMed ID: 28213517
[TBL] [Abstract][Full Text] [Related]
2. TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.
Drané P; Brault ME; Cui G; Meghani K; Chaubey S; Detappe A; Parnandi N; He Y; Zheng XF; Botuyan MV; Kalousi A; Yewdell WT; Münch C; Harper JW; Chaudhuri J; Soutoglou E; Mer G; Chowdhury D
Nature; 2017 Mar; 543(7644):211-216. PubMed ID: 28241136
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR.
Dai Y; Zhang A; Shan S; Gong Z; Zhou Z
Nat Commun; 2018 May; 9(1):2123. PubMed ID: 29844495
[TBL] [Abstract][Full Text] [Related]
4. TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs.
Parnandi N; Rendo V; Cui G; Botuyan MV; Remisova M; Nguyen H; Drané P; Beroukhim R; Altmeyer M; Mer G; Chowdhury D
Mol Cell; 2021 Jun; 81(12):2583-2595.e6. PubMed ID: 33961797
[TBL] [Abstract][Full Text] [Related]
5. DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociation.
Ketley RF; Battistini F; Alagia A; Mondielli C; Iehl F; Balikçi E; Huber KVM; Orozco M; Gullerova M
Cell Rep; 2022 Oct; 41(4):111526. PubMed ID: 36288694
[TBL] [Abstract][Full Text] [Related]
6. Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1.
Zhang F; Gong Z
J Zhejiang Univ Sci B; 2021 Jan; 22(1):38-46. PubMed ID: 33448186
[TBL] [Abstract][Full Text] [Related]
7. Nudix Hydrolase NUDT16 Regulates 53BP1 Protein by Reversing 53BP1 ADP-Ribosylation.
Zhang F; Lou L; Peng B; Song X; Reizes O; Almasan A; Gong Z
Cancer Res; 2020 Mar; 80(5):999-1010. PubMed ID: 31911551
[TBL] [Abstract][Full Text] [Related]
8. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
[TBL] [Abstract][Full Text] [Related]
9. FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function.
Tang M; Feng X; Pei G; Srivastava M; Wang C; Chen Z; Li S; Zhang H; Zhao Z; Li X; Chen J
Cell Rep; 2020 Aug; 32(6):108018. PubMed ID: 32783940
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the inhibition of the methyl-lysine binding function of 53BP1 by TIRR.
Wang J; Yuan Z; Cui Y; Xie R; Yang G; Kassab MA; Wang M; Ma Y; Wu C; Yu X; Liu X
Nat Commun; 2018 Jul; 9(1):2689. PubMed ID: 30002377
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of 53BP1 dictates the DNA double strand break repair pathway.
Guo X; Bai Y; Zhao M; Zhou M; Shen Q; Yun CH; Zhang H; Zhu WG; Wang J
Nucleic Acids Res; 2018 Jan; 46(2):689-703. PubMed ID: 29190394
[TBL] [Abstract][Full Text] [Related]
12. HDGFRP3 interaction with 53BP1 promotes DNA double-strand break repair.
Zhang Z; Samsa WE; De Y; Zhang F; Reizes O; Almasan A; Gong Z
Nucleic Acids Res; 2023 Mar; 51(5):2238-2256. PubMed ID: 36794849
[TBL] [Abstract][Full Text] [Related]
13. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
[TBL] [Abstract][Full Text] [Related]
14. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
[TBL] [Abstract][Full Text] [Related]
15. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
[TBL] [Abstract][Full Text] [Related]
16. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
[TBL] [Abstract][Full Text] [Related]
17. CHAMP1-POGZ counteracts the inhibitory effect of 53BP1 on homologous recombination and affects PARP inhibitor resistance.
Fujita H; Ikeda M; Ui A; Ouchi Y; Mikami Y; Kanno SI; Yasui A; Tanaka K
Oncogene; 2022 May; 41(19):2706-2718. PubMed ID: 35393543
[TBL] [Abstract][Full Text] [Related]
18. Regulation of DNA repair in the absence of classical non-homologous end joining.
Kang YJ; Yan CT
DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
[TBL] [Abstract][Full Text] [Related]
19. The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
